DrugCoat: Advanced Methacrylic Acid Copolymers

Enteric coating

L & S Series

DRUGCOAT SERIES	MONOGRAPHS	PHYSICAL FORM	DISSOLUTION PROPERTIES
Aqueous enteric coating
DRUGCOAT L30D	USP/NF: Methacrylic Acid and Ethyl Acrylate Copolymer Dispersion Ph. Eur: Methacrylic Acid–Ethyl Acrylate Copolymer (1:1) Dispersion 30%	Aqueous Dispersion 30%	Dissolve above pH 5.5
DRUGCOAT L100-55	USP/NF: Methacrylic Acid–Ethyl Acrylate Copolymer Ph. Eur.: Methacrylic Acid- Ethyl Acrylate Copolymer (1:1) Type A	Powder
DRUGCOAT L100-55D	USP/NF: Partially Neutralized Methacrylic Acid & Ethyl Acrylate Copolymer Ph. Eur: Methacrylic Acid–Ethyl Acrylate Copolymer (1:1) Type B	Powder
Non-aqueous enteric coating
DRUGCOAT L100	USP/NF: Methacrylic Acid and Methyl Methacrylate Copolymer (1:1) Ph. Eur: Methacrylic Acid – Methyl Methacrylate Copolymer (1:1)	Powder	Dissolve above pH 6.0
DRUGCOAT L12.5		Organic Solution 12.5%	Dissolve above pH 6.0
Colon targeted enteric coating
DRUGCOAT S100	USP/NF: Methacrylic Acid and Methyl Methacrylate Copolymer (1:2) Ph. Eur: Methacrylic Acid – Methyl Methacrylate Copolymer (1:2)	Powder	Dissolve above pH 7.0
DRUGCOAT S12.5		Organic Solution 12.5%
DRUGCOAT FS 30D	USP/NF : Methyl Acrylate, Methyl Methacrylate and Methacrylic Acid (7:3:1) Copolymer Dispersion.	Aqueous Dispersion 30%

Taste masking

E Series

DRUGCOAT SERIES	MONOGRAPHS	PHYSICAL FORM	DISSOLUTION PROPERTIES
DRUGCOAT E 100	USP/NF: Amino Methacrylate Copolymer Ph. Eur.: Basic Butylated Methacrylate Copolymer	Granules	Dissolve up to pH 5.0 Soluble in Gastric Fluid
DRUGCOAT E PO		Powder
DRUGCOAT E 12.5		Organic Solution 12.5%

Sustained release

RL/RS & NE Series

DRUGCOAT SERIES	MONOGRAPHS	PHYSICAL FORM	DISSOLUTION PROPERTIES
DRUGCOAT RL 100	USP/NF: Ammonio Methacrylate Copolymer, Type A Ph. Eur.: Ammonio Methacrylate Copolymer, Type A	Granules	pH-independent swelling
DRUGCOAT RL PO		Powder
DRUGCOAT RL 12.5		Organic Solution 12.5%
DRUGCOAT RS 100	USP/NF: Ammonio Methacrylate Copolymer, Type B Ph. Eur.: Ammonio Methacrylate Copolymer, Type B	Granules
DRUGCOAT RS PO		Powder
DRUGCOAT RS 12.5		Organic Solution 12.5%
DRUGCOAT NE 30D	USP/NF: Ethyl Acrylate And Methyl Methacrylate Copolymer Dispersion Ph. Eur.: Polyacrylate Dispersion 30%	Aqueous Dispersion 30%

FAQs

A few questions answered

What is DRUGCOAT, and how does it enhance drug formulations?

DRUGCOAT is a versatile coating system by Vikram thermo pharma that improves stability, taste masking, and release control in drug formulations. It’s built on advanced polymethyl acrylate technology for reliable performance.

Can DRUGCOAT be used for colon-targeted drug delivery?

Yes, DRUGCOAT supports colon-specific delivery by using pH-sensitive polymethyl acrylate coatings that dissolve only in targeted intestinal environments. Thermo Pharma’s research ensures precise release control.

What are the benefits of using methacrylic copolymers in pharmaceutical formulations?

Methacrylic copolymers like polymethyl acrylate offer pH-dependent solubility, sustained release, and improved drug stability. Thermo Pharma leverages these polymers for effective therapeutic outcomes.

Are DRUGCOAT products suitable for aqueous and non-aqueous coatings?

DRUGCOAT is engineered for compatibility with both aqueous and non-aqueous systems, making it ideal for diverse applications. Polymethyl acrylate plays a key role in this flexibility.

How does DRUGCOAT ensure compliance with international pharmaceutical standards?

All DRUGCOAT products follow global regulatory norms including USP, EP, and JP standards. Thermo Pharma ensures quality by using high-grade polymethyl acrylate-based polymers in its formulations.

The smarter way to coat

Why DRUGCOAT works better

DRUGCOAT®

Certified to perform globally

A few questions answered